NASDAQ:MYOS
Delisted
MYOS Corporation Stock News
$11.40
+0 (+0%)
At Close: May 27, 2022
MYOS RENS Announces that Multiple Top-Tier Pet Insurance Companies Now Cover its Canine Nutrition Products
12:00pm, Tuesday, 28'th Apr 2020
MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition that helps build lean muscle, announced t
MYOS RENS Announces Publication Of Landmark Clinical Study On Recovery In Dogs Following TPLO Surgery
12:09pm, Wednesday, 15'th Apr 2020MYOS RENS Announces Publication of Landmark Clinical Study on Recovery in Dogs Following TPLO Surgery
12:00pm, Wednesday, 15'th Apr 2020
MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a biotherapeutics and bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition that helps build lean
Edited Transcript of MYOS earnings conference call or presentation 25-Mar-20 3:00pm GMT
06:26am, Monday, 30'th Mar 2020
Q4 2019 MYOS RENS Technology Inc Earnings Call
MYOS RENS Technology, Inc. to Host Earnings Call
01:00pm, Wednesday, 25'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 25, 2020 / MYOS RENS Technology, Inc. (NASDAQ:MYOS) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 25, 2020
MYOS RENS Technology Reports a 187% Increase in Net Revenues for the Year Ended December 31, 2019
10:00am, Wednesday, 25'th Mar 2020
MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertilized egg yolk t
Earnings Scheduled For March 25, 2020
08:54am, Wednesday, 25'th Mar 2020
Companies Reporting Before The Bell
Paychex, Inc. (NASDAQ: PAYX) is projected to report quarterly earnings at $0.96 per share on revenue of $1.14 billion.
Winnebago Industries,...
MYOS RENS Technology Announces Date of Fourth Quarter 2019 Financial Results, Conference Call and Webcast
12:00pm, Thursday, 19'th Mar 2020
MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition made from fertilized egg yolk that
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
11:37am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commen
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
MYOS RENS Partners with UNFI, a Nationwide Distributor of Natural, Organic and Specialty Food
12:00pm, Thursday, 12'th Mar 2020
MYOS RENS Technology, Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition made from fertilized egg yolk tha
MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition made from fertilized egg yolk that helps
